The FDA has approved the VenaSeal closure system (VenaSeal system) from Covidien, to permanently treat varicose veins of the legs...
Aethoxysklerol is indicated for sclerotherapy of varicose veins of the lower extremities.
Results from VANISH-2, the first of two US pivotal Phase III trials of Varisolve (polidocanol endovenous microfoam), from BTG, for...
VANISH-2, the first of two US Phase III studies comparing Varisolve (polidocanol endovenous microfilm) from BTG with placebo in patients...
BTG plc announced that the FDA has approved Varithena (polidocanol injectable foam) for the treatment of patients with incompetent veins...
For the treatment of uncomplicated primary varicose veins, recurrent or residual varicose veins following surgery, reticular veins, venules and spider veins of the lower extremities that show simple dilation.
This guideline covers diagnosing and managing varicose veins in people aged 18 and over.
Covidien plc announced that it has acquired Sapheon, Inc., a privately-held developer of venous disease treatments. Financial terms of the...